The article highlights the complexity of Canada's pharmaceutical supply chain and the critical need for collaboration among stakeholders to ensure reliable access to medicines.

Angelique Berg, president of Vital, Canada’s Pharmaceutical Supply Chain Alliance, emphasizes that the system faces challenges like growing healthcare demand, global disruptions, and evolving patient needs.Collaboration across distributors, manufacturers, healthcare professionals, and governments is essential to build resilience.

A 2025 report titled 'A Path Forward' outlines five priorities, including improving information sharing, diversifying supply chains, and enhancing regulatory agility.The initiative involved multi-stakeholder summits to address drug shortages and identify actionable solutions.

Simona Zar, senior vice president at Vital, stresses the importance of integrating supply chain expertise into healthcare planning, particularly for pharmaceutical sovereignty and crisis preparedness.

The article underscores that equitable access to medicines remains the ultimate measure of success, requiring a shared vision and evidence-based solutions among stakeholders.